BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2016

Feb 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2016-01-29

Reporting Person: Barnes Alane P (VP, General Counsel & Corp Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-29	Common Stock	M	19368	$1.42	Acquired	85057	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-29	Emp. Stock Option (Right to Buy)	$1.42	M	19368	Disposed	2023-01-01	Common Stock (19368)	Direct